Cargando…
A novel biomarker assay for cancer immunotherapy development based on myeloid derived supressor cells (MDSCs)
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991266/ http://dx.doi.org/10.1186/2051-1426-1-S1-P103 |
_version_ | 1782312404619624448 |
---|---|
author | Hepburne-Scott, Henry |
author_facet | Hepburne-Scott, Henry |
author_sort | Hepburne-Scott, Henry |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-3991266 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-39912662014-05-05 A novel biomarker assay for cancer immunotherapy development based on myeloid derived supressor cells (MDSCs) Hepburne-Scott, Henry J Immunother Cancer Poster Presentation BioMed Central 2013-11-07 /pmc/articles/PMC3991266/ http://dx.doi.org/10.1186/2051-1426-1-S1-P103 Text en Copyright © 2013 Hepburne-Scott; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Poster Presentation Hepburne-Scott, Henry A novel biomarker assay for cancer immunotherapy development based on myeloid derived supressor cells (MDSCs) |
title | A novel biomarker assay for cancer immunotherapy development based on myeloid derived supressor cells (MDSCs) |
title_full | A novel biomarker assay for cancer immunotherapy development based on myeloid derived supressor cells (MDSCs) |
title_fullStr | A novel biomarker assay for cancer immunotherapy development based on myeloid derived supressor cells (MDSCs) |
title_full_unstemmed | A novel biomarker assay for cancer immunotherapy development based on myeloid derived supressor cells (MDSCs) |
title_short | A novel biomarker assay for cancer immunotherapy development based on myeloid derived supressor cells (MDSCs) |
title_sort | novel biomarker assay for cancer immunotherapy development based on myeloid derived supressor cells (mdscs) |
topic | Poster Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991266/ http://dx.doi.org/10.1186/2051-1426-1-S1-P103 |
work_keys_str_mv | AT hepburnescotthenry anovelbiomarkerassayforcancerimmunotherapydevelopmentbasedonmyeloidderivedsupressorcellsmdscs AT hepburnescotthenry novelbiomarkerassayforcancerimmunotherapydevelopmentbasedonmyeloidderivedsupressorcellsmdscs |